A better way to address Covid-19 vaccine hesitancy: Listening, engaging, and moving forward

As of mid-November 2021, the US Covid-19 death toll is about 757,000 from 47 million cases. There is broad consensus across the medical community that the most effective way for individuals to avoid the most serious consequences of Covid and for communities to stop the spread is through vaccination. With the Delta variant mostly in …



The Case for CGM: Where does it fit in Primary Care?

Practice Points - The Case For CGM

Treatment of diabetes is a growing concern in the United States. In addition to being a significant challenge for individual patient management, diabetes is a burden on the healthcare system’s resources, especially its primary care physicians (PCPs). Thirty-four million people have diabetes (the overwhelming majority have type 2 diabetes), and 90% of patients with diabetes …



The Case for CGM: Who Will Benefit Most from CGM Adoption?

Practice Points - The Case For CGM

Prescribing the right drug for the right patient is important for obtaining the best clinical results. The same concept is applicable to medical devices; choosing the proper device to fit the patient can make a world of difference in achieving the desired result. Theoretically, a continuous glucose monitor (CGM) can be a benefit to anyone …



The Case for CGM: Who May Not Be a Good Candidate for CGM?

Practice Points - The Case For CGM

Personal continuous glucose monitors (CGMs) have been a salvation for many patients with diabetes, their caregivers, and their healthcare providers. They have introduced a world of glucose data that were previously unavailable via fingerstick monitoring and that can provide new insights. From a strictly technological standpoint, CGMs could help every person with diabetes improve their …



The Case for CGM – Why Silver Fern Healthcare added CGM to its Type 2 Diabetes Program

Practice Points - The Case For CGM

Silver Fern Healthcare recently integrated the topic of continuous glucose monitoring (CGM) into its Type 2 Diabetes Program on its Behavior Diagnostic Platform. We felt it was essential that clinicians were covering the topic of CGM with their patients as the technology continues to gain acceptance and is more widely available to people with type …



Empowering families to be healthier and happier in 2021 and beyond

Our previous posts have highlighted the dramatic and recent changes in lifestyles in the US, most impactfully changes in our national diet, which have created an epidemic of obesity and chronic health conditions. This post explores the opportunity for us to have a national focus, led by emerging new healthcare innovators, on the family unit …



Silver Fern Wraps Up 2020 Adding Hypertension Program to Its Proven Platform

On December 21, 2020, Silver Fern Healthcare released Hypertension, the newest chronic disease program featured on its proven Behavior Diagnostic Platform. This Platform provides chronic care management teams with previously inaccessible insights to improve treatment plans and achieve better health outcomes for people with chronic diseases. The Hypertension Program applies Silver Fern’s evidence-based techniques for …